Company: ERAS
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103868
Chunk: 41

Company: Erasca, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 41
---
 |
|:-------------------------------|:----|:------|:----------|:----|:-----------|--------:|:----|:-----------------|-----:|:----|:--------------|--------:|:----|:----------------------------|:------|:---|
| Jonathan E. Lim, M.D.          |     |       | 6/20/2024 |     |            | 632,759 |     | $                | 2.03 |     | $             | 934,458 |     |                             | (1.43 | %) |
| David M. Chacko, M.D.          |     |       | 6/20/2024 |     |            | 278,812 |     | $                | 2.03 |     | $             | 411,750 |     |                             | (1.43 | %) |
| Shannon R. Morris, M.D., Ph.D. |     |       | 6/20/2024 |     |            | 137,142 |     | $                | 2.03 |     | $             | 202,531 |     |                             | (1.43 | %) |

27

The timing of any equity grants to newly-hired employees, or in connection with promotions or other non-routinegrants, is generally tied to the event giving rise to the award, although non-executivenew hire stock option awards are generally approved at the beginning of the calendar month following the individual’s commencement of employment. For all stock option awards, the exercise price is no less than the closing price of our common stock on the date of the grant. The following table sets forth information for certain stock options granted to our NEOs during 2024. In the event an issuer grants stock options or option-like instruments within the period commencing four business days prior to and ending one business day following the filing by the Company of a Form 10-K,Form 10-Qor Form 8-Kcontaining material non-publicinformation as required under Item 402(x) of Regulation S-K,Item 402(x) of Regulation S-Krequires tabular disclosure of certain information related to such awards. The table below is being provided because certain of the stock options granted to our NEOs during 2024 were granted within the period commencing four business days prior to and ending one business day following the filing by the Company of a Form 10-K,Form 10-Qor Form